DynAMo: A dynamic allocation modular sequential trial of approved and promising therapies in men with metastatic CRPC.

Authors

Paul Viscuse

Paul Vincent Viscuse

University of Texas MD Anderson Cancer Center, Houston, TX

Paul Vincent Viscuse , Rebecca Tidwell , Jingjing Liu , Shuai Guo , Haswanth Vundavilli , Miao Zhang , Sumit Kumar Subudhi , Amado J. Zurita , Paul Gettys Corn , Shi-Ming Tu , John C. Araujo , Jennifer Wang , Eleni Efstathiou , Jianbo Wang , Patrick Glen Pilié , Patricia Troncoso , Jianhua Zhang , Wenyi Wang , Christopher Logothetis , Ana Aparicio

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT02703623

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5059)

DOI

10.1200/JCO.2022.40.16_suppl.5059

Abstract #

5059

Poster Bd #

242

Abstract Disclosures